The validation of the standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30) in pre-operative patients with brain tumor in China

BMC Medical Research Methodology

Volumn 11, Issue , 2011, Pages

  Cheng, Jin Xiang ^a   Liu, Bo Lin ^a   Zhang, Xiang ^a   Zhang, Yong Qiang ^a   Lin, Wei ^a   Wang, Rui ^b   Zhang, Yong Qin ^a   Zhang, Hong Ying ^a   Xie, Li ^a   Huo, Jun Li ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN TUMOR; CHINA; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; SELF REPORT; SICKNESS IMPACT PROFILE; STATISTICAL ANALYSIS; VALIDATION STUDY;

BRAIN NEOPLASMS; CHINA; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF REPORT; SICKNESS IMPACT PROFILE;

EID: 79955030815     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-11-56     Document Type: Article

References (25)

1. Global cancer statistics, 2002. DM Parkin F Bray J Ferlay P Pisani, CA: a cancer journal for clinicians 2005 55 2 74 108 10.3322/canjclin.55.2.74 (Pubitemid 40372904)
2. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. NK Aaronson S Ahmedzai B Bergman M Bullinger A Cull NJ Duez A Filiberti H Flechtner SB Fleishman JC de Haes,, et al. Journal of the National Cancer Institute 1993 85 5 365 376 10.1093/jnci/85.5.365 8433390 (Pubitemid 23073154)
3. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. D Osoba NK Aaronson M Muller K Sneeuw MA Hsu WK Yung M Brada E Newlands, Qual Life Res 1996 5 1 139 150 10.1007/BF00435979 8901377 (Pubitemid 26100512)
4. The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. MA Weitzner CA Meyers CK Gelke KS Byrne DF Cella VA Levin, Cancer 1995 75 5 1151 1161 10.1002/1097-0142(19950301)75:5<1151::AID- CNCR28207505153.0.CO;2-Q 7850714
5. Testing psychometric properties of the standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30). H Zhao K Kanda, J Epidemiol 2004 14 6 193 203 10.2188/jea.14.193 15617393 (Pubitemid 41403878)
6. Health-related quality of life in patients with high-grade glioma. JX Cheng X Zhang BL Liu, Neuro-oncology 2009 11 1 41 50 18628405
7. Health-related quality of life of long-term high-grade glioma survivors. I Bosma JC Reijneveld L Douw MJ Vos TJ Postma NK Aaronson M Muller WP Vandertop BJ Slotman MJ Taphoorn,, et al. Neuro-oncology 2009 11 1 51 58 18617599
8. Quality of life in low-grade glioma patients receiving temozolomide. R Liu K Solheim MY Polley KR Lamborn M Page A Fedoroff J Rabbitt N Butowski M Prados SM Chang, Neuro-oncology 2009 11 1 59 68 18713953
9. Effect of disease burden on health-related quality of life in patients with malignant gliomas. D Osoba M Brada MD Prados WK Yung, Neuro-oncology 2000 2 4 221 228 11265231
10. Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma. D Osoba NK Aaronson M Muller K Sneeuw MA Hsu WK Yung M Brada E Newlands, Journal of neuro-oncology 1997 34 3 263 278 10.1023/A:1005790632126 9258818 (Pubitemid 27344576)
11. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. DF Cella DS Tulsky G Gray B Sarafian E Linn A Bonomi M Silberman SB Yellen P Winicour J Brannon,, et al. J Clin Oncol 1993 11 3 570 579 8445433 (Pubitemid 23071057)
12. Cognitive impairment among elderly adults in Shanghai, China. ES Yu WT Liu P Levy MY Zhang R Katzman CT Lung SC Wong ZY Wang GY Qu, J Gerontol 1989 44 3 97 106 2715594
13. The use of nitrogen mustards in the palliative treatment of carcinoma. DA Karnofsky WH Abelman LF Craver JH Burchenal, Cancer 1948 1 634 656 10.1002/1097-0142(194811)1:4<634::AID-CNCR28200104103.0.CO;2-L
14. A Chinese version of the Mini-Mental State Examination; impact of illiteracy in a Shanghai dementia survey. R Katzman MY Zhang Q Ouang Ya ZY Wang WT Liu E Yu SC Wong DP Salmon I Grant, J Clin Epidemiol 1988 41 10 971 978 10.1016/0895-4356(88)90034-0 3193141 (Pubitemid 19002065)
15. rd Edition). PM Fayers Aaronson M Groenvold D Curran B A, the EORTC Quality of Life Group European Organisation for Research and Treatment of Cancer, Brussels 2001
16. Translation and validation of the standard Chinese version of the EORTC QLQ-C30. H Zhao K Kanda, Qual Life Res 2000 9 2 129 137 10.1023/A:1008981520920 10983477
17. EORTC QLQ-C30 Reference Values. Neil W Scott Peter M Fayers Neil K Aaronson Bottomley Andrew Alexander de Graeff Groenvold Mogens Gundy Chad Koller Michael Morten A Petersen MA Sprangers, the EORTC Quality of Life Department European Organisation for Research and Treatment of Cancer, Brussels 2001
18. Radiotherapy for glioblastoma in the elderly. F Keime-Guibert O Chinot L Taillandier S Cartalat-Carel M Frenay G Kantor JS Guillamo E Jadaud P Colin PY Bondiau,, et al. The New England journal of medicine 2007 356 15 1527 1535 10.1056/NEJMoa065901 17429084 (Pubitemid 46588417)
19. Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation. VA Levin S Phuphanich WK Yung PA Forsyth RD Maestro JR Perry GN Fuller M Baillet, Journal of neuro-oncology 2006 78 3 295 302 10.1007/s11060-005-9098-5 16636750 (Pubitemid 44018824)
20. High-grade astrocytoma treated concomitantly with estramustine and radiotherapy. R Henriksson A Malmstrom P Bergstrom G Bergh T Trojanowski L Andreasson E Blomquist S Jonsborg T Edekling P Salander,, et al. Journal of neuro-oncology 2006 78 3 321 326 10.1007/s11060-005-9106-9 16598426 (Pubitemid 44018828)
21. Health-related quality of life in patients with glioblastoma: a randomised controlled trial. MJ Taphoorn R Stupp C Coens D Osoba R Kortmann MJ van den Bent W Mason RO Mirimanoff BG Baumert E Eisenhauer,, et al. The lancet oncology 2005 6 12 937 944 10.1016/S1470-2045(05)70432-0 16321761 (Pubitemid 41685226)
22. Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial. MJ Taphoorn MJ van den Bent ME Mauer C Coens JY Delattre AA Brandes PA Sillevis Smitt HJ Bernsen M Frenay CC Tijssen,, et al. J Clin Oncol 2007 25 36 5723 5730 10.1200/JCO.2007.12.7514 18089866
23. Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme. D Osoba M Brada WK Yung M Prados, J Clin Oncol 2000 18 7 1481 1491 10735896 (Pubitemid 30205394)
24. Health-related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide. D Osoba M Brada WK Yung MD Prados, Eur J Cancer 2000 36 14 1788 1795 10.1016/S0959-8049(00)00165-9 10974627 (Pubitemid 30639499)
25. The presigmoid approach to anterolateral pontine cavernomas. EF Hauck SL Barnett JA White D Samson, Journal of Neurosurgery 2010 113 4 701 708 10.3171/2010.1.JNS08413 20302394